Search Results
Keyword：radioisotope production
Kazakhstan's Institute of Nuclear Physics Plans to Expand Medical Radioisotope Production and Export
The Institute of Nuclear Physics (INP) of Kazakhstan is progressively expanding the applications of radioisotopes and radiation technologies, with related products already used in cancer diagnosis and treatment, industrial production, and scientific research. Institute Director Sayabek Sakhiyev stated that radioisotope and radiopharmaceutical production is one of the institute's key applied activities, covering the full chain from scientific research and research reactor operation to radiochemical technology development and medical applications. Currently, INP produces three main categories of radiopharmaceuticals: sodium iodide I-131 for thyroid disease treatment, Mo-99/Tc-99m related products for radionuclide diagnostics, and...
2026-08-18
Turkey's TR-2 Research Reactor Receives Operating License
The Turkish Nuclear Regulatory Authority has issued an operating license for the TR-2 research reactor at the Istanbul campus of the Nuclear Energy Institute under the Turkish Energy, Nuclear and Mineral Research Agency (TENMAK). The license was issued pursuant to the Authority's Decision No. 2026-34/3 dated August 6, 2026. Following the review and evaluation of TENMAK's application documents, the Turkish Nuclear Regulatory Authority authorized the agency to carry out the activities required for the transition of the TR-2 research reactor from its current status to the operational phase. TR-2 is located at the Istanbul campus of TENMAK's Nuclear Energy Institute, with an approved thermal power of 5 megawatts. The facility is a research reactor and is not a nuclear facility primarily intended for power generation. According to...
2026-08-17